FDA Approves First Lower-Cost Biotech Drug

Other discussions not related to the Permanent Portfolio

Moderator: Global Moderator

Post Reply
User avatar
MachineGhost
Executive Member
Executive Member
Posts: 10054
Joined: Sat Nov 12, 2011 9:31 am

FDA Approves First Lower-Cost Biotech Drug

Post by MachineGhost »

This is an unexpected surprise and a game changer.

[quote=http://www.nytimes.com/aponline/2015/03 ... h-fda.html]In the U.S., pharmacies and insurers cannot automatically switch patients from a brand-name biologic to a biosimilar, which is allowed for generic versions of traditional drugs. But if state law allows, pharmacists could call doctors and ask them to consider such switches, FDA officials said.

And if biosimilar drugmakers apply to the FDA for a designation called "interchangeability," automatic switches to the cheaper biosimilar drug would be allowed. Novartis didn't seek that classification for its drug, but analysts expect other companies will, expanding the market for biosimilars to $20 billion by 2020, according to Leerink Swann analysts.[/quote]
"All generous minds have a horror of what are commonly called 'Facts'. They are the brute beasts of the intellectual domain." -- Thomas Hobbes

Disclaimer: I am not a broker, dealer, investment advisor, physician, theologian or prophet.  I should not be considered as legally permitted to render such advice!
Post Reply